Pre-clinical drug candidates
Many proteins and vaccines that are in development lack sufficient stability to advance as drug candidates. Stabilisation can require costly additional processing and/or limits the types of presentation.
Arestat™ stabilisation allows progression of drug candidates that would otherwise be discarded, and widens the presentation options.
Last updated: 13 June 2008